Tyrphostin AG 835,
133550-37-5,
Tyrphostin B50,
Tyrphostin B44, (+) enantiomer,
MFCD00209855,
Tyrphostin Ag-835,
Tocris-0579,
Tyrphostin deriv. 50,
AC1NS5AU,
Lopac-T-4443,
Lopac-T-5568,
Lopac0_001198,
BDBM4305,
CHEMBL261557,
SCHEMBL12856415,
Tyrphostin AG 835, >=92%,
HMS3263P17,
HMS3266M20,
HMS3678G21,
ZINC2557951,
Tox21_501198,
BS0197,
HSCI1_000020,
AKOS024458569,
CCG-205272,
LP01198,
NCGC00016022-01,
NCGC00016022-02,
NCGC00024663-01,
NCGC00024663-02,
NCGC00024663-03,
NCGC00024663-04,
NCGC00261883-01,
EU-0101198,
T3540,
T 5568,
SR-01000597624,
SR-01000597624-1,
BRD-K17415526-001-02-7,
(S)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(1-phenylethyl)acrylamide,
(S)-N-(alpha-Methylbenzyl)-3,4-dihydroxybenzylidenecyanoacetamide,
(S,E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(1-phenylethyl)acrylamide,
2-Cyano-3-(3,4-dihydroxyphenyl)-N-[(S)-1-phenylethyl]acrylamide,
(+)-(S)-N-(alpha-Methylbenzyl)-3,4-dihydroxy-benzylidenecyanoacetamide,
(+)-(S)-N-(alpha-Methylbenzyl)-3,4-dihydroxybenzylidenecyanoacetamide,
(2E)-2-Cyano-3-(3,4-Dihydroxyphenyl)-N-[(1S)-1-Phenylethyl]-2-Propenamide,
(2E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]prop-2-enamide,
(E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-[(1S)-1-phenylethyl]prop-2-enamide,
(S)-(E)-2-Cyano-3-(3',4'-dihydroxyphenyl)-N-(1-phenylethyl)-2-propenamide,
(S)-N-(alpha-Methylbenzyl)-3,4-dihydroxybenzylidenecyanoacetamide / (S)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-(1-phenylethyl)acrylamide,
Tyrphostin B44,
TYRPHOSTINAG835,
CID5328769,